These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10563710)

  • 1. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations.
    Christeff N; Melchior JC; de Truchis P; Perronne C; Nunez EA; Gougeon ML
    AIDS; 1999 Nov; 13(16):2251-60. PubMed ID: 10563710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome.
    Christeff N; Melchior JC; de Truchis P; Perronne C; Gougeon ML
    Eur J Clin Invest; 2002 Jan; 32(1):43-50. PubMed ID: 11851726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evolution of HIV-1-associated lipodystrophy is correlated to serum cortisol:DHEA ratio and IFN-alpha.
    Christeff N; De Truchis P; Melchior JC; Perronne C; Gougeon ML
    Eur J Clin Invest; 2002 Oct; 32(10):775-84. PubMed ID: 12406027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cortisol/DHEA ratio in HIV-infected men are related to immunological and metabolic perturbations leading to malnutrition and lipodystrophy.
    Christeff N; Nunez EA; Gougeon ML
    Ann N Y Acad Sci; 2000; 917():962-70. PubMed ID: 11268428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does race protect an oriental population from developing lipodystrophy in HIV-infected individuals on HAART?
    Chang KH; Kim JM; Song YG; Hong SK; Lee HC; Lim SK
    J Infect; 2002 Jan; 44(1):33-8. PubMed ID: 11972416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
    Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between increased cortisol:DHEA ratio and malnutrition in HIV-positive men.
    Christeff N; Melchior JC; Mammes O; Gherbi N; Dalle MT; Nunez EA
    Nutrition; 1999; 15(7-8):534-9. PubMed ID: 10422082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy.
    Petit JM; Duong M; Duvillard L; Florentin E; Portier H; Lizard G; Brun JM; Gambert P; Verges B
    Eur J Clin Invest; 2002 May; 32(5):354-9. PubMed ID: 12027876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.
    Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L
    Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.
    Shahmanesh M; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Cramb R; Nightingale P; Umpleby AM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):755-60. PubMed ID: 15522931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
    Behrens G; Dejam A; Schmidt H; Balks HJ; Brabant G; Körner T; Stoll M; Schmidt RE
    AIDS; 1999 Jul; 13(10):F63-70. PubMed ID: 10416516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
    Negredo E; Ribalta J; Paredes R; Ferré R; Sirera G; Ruiz L; Salazar J; Reiss P; Masana L; Clotet B
    AIDS; 2002 Jul; 16(10):1383-9. PubMed ID: 12131215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating hyperlipidaemia associated with antiretroviral therapy.
    Mauss S; Stechel J; Willers R; Schmutz G; Berger F; Richter WO
    AIDS; 2003 Jan; 17(2):189-94. PubMed ID: 12545078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    AIDS; 2002 Nov; 16(16):2183-93. PubMed ID: 12409740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal C19 steroids and serum lipoprotein levels in healthy men.
    Vatalas IA; Dionyssiou-Asteriou A
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):388-93. PubMed ID: 12055703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.
    Hatano H; Miller KD; Yoder CP; Yanovski JA; Sebring NG; Jones EC; Davey RT
    AIDS; 2000 Sep; 14(13):1935-42. PubMed ID: 10997397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).
    Dong KL; Bausserman LL; Flynn MM; Dickinson BP; Flanigan TP; Mileno MD; Tashima KT; Carpenter CC
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):107-13. PubMed ID: 10360801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.